4 Ways To Explore a Whole New Level of You with Cannabis

By pretty much any measure, 2020 has been…a lot. As parents, we’re navigating school in a way that literally no one has ever done before. Whether it’s virtual or in-person, it’s challenging. And that’s on top of fire tornados and murder hornets (really?!). If there was ever a time to level-up yourself, it’s right. flipping. now.

Parents need to be cognizant of maintaining their mental health now more than ever. Yep, it’s time to supercharge yourself. No matter your preferred mode of de-stressing — a warm bath, a few yoga poses, creating something — adding cannabis may take your practice to the next level. Here are some ideas to power up your “me time.”

RELATED: What to Know About Medical Cannabis And Getting A Medical Marijuana Card

Awaken Your Muses

Scientists studying brain scans have discovered that moments of creativity happen more often when the mind is at rest rather than when we’re “working on” something. Cannabis can be an incredible tool for creativity, helping you to approach both artistic endeavors and problem solving with an open and more accepting mind.

Something as simple as an adult coloring book and a cup full of colored pencils and markers can inspire creative self-expression. Even if you don’t think of yourself as an artist, literally anyone can have fun playing with color.

Trying a new artistic medium is another way to awaken your creativity. If you’re a painter, try sculpting. If you play music, learn to draw. You’ll find your brain working in new and unexpected ways – and you may discover something new to love. Adding cannabis micro-tablets to your de-stressing routine may help you find more creative space.

When Feeling Anxious Try a Tale of True Crime

When feeling anxious, reading or listening to chilling tales of real-life crime might be more relaxing than an Enya CD. If you know, you know. Enhance the experience of a new read by pairing it with cannabis flower pods depending on state availability.

Find Your Om

One of the principal reasons people do yoga is for relaxation. Same for cannabis. So, what if you combined the two?! At home, you may find yourself more relaxed, focused and flexible doing yoga after using a THC vape pen. Start slow and see what experience you feel. Meditation is another wildly popular way to find calm. If you’re new to it, try a meditation app like Headspace or Calm and try a guided meditation or two.

RELATED: Feeling Extra Bendy? Give These These (Hard!) Advanced Yoga Poses A Shot

Use Your Phone

Nope, not to mindlessly scroll Instagram. Use your phone to set up periodic wellness self-checks. If you find yourself getting wound up mid-morning (hello, distance learning!) set up a reminder to go for a short walk. As little as five minutes can be a total reset. After a long day of Zoom meetings, let your phone remind you to take a wellness break with a THC tincture.

Another simple way to turn your timer into a wellness tool is to set an alarm to go off every few hours. When you hear it, that’s your reminder to MASH for 5-10 minutes. What’s MASH? Meditate, Get fresh Air, Stretch your body and Hydrate. Don’t wait ‘til you’re a frazzled mess to practice the basics.

Taking care of yourself is critical, especially for parents. Wherever you find your alone time, cannabis can help you make the most of it.

Curaleaf is cannabis with confidence. Learn more and find a Curaleaf dispensary here.

Disclaimers & Qualifying Conditions:

Connecticut: Qualifying Conditions: For Adults, Debilitating Medical Conditions Include: Cancer (Effective 2012), Glaucoma (Effective 2012), Positive Status for Human Immunodeficiency Virus or Acquired Immune Deficiency Syndrome (Effective 2012), Parkinson’s Disease (Effective 2012), Multiple Sclerosis (Effective 2012), Damage to the Nervous Tissue of the Spinal Cord with Objective Neurological Indication of Intractable Spasticity (Effective 2012), Epilepsy (Effective 2012), Cachexia (Effective 2012), Wasting Syndrome (Effective 2012), Crohn’s Disease (Effective 2012), Post-Traumatic Stress Disorder (Effective 2012), Sickle Cell Disease (Effective 2016)*, Post Laminectomy Syndrome with Chronic Radiculopathy (Effective 2016)*, Severe Psoriasis and Psoriatic Arthritis (Effective 2016)*, Amyotrophic Lateral Sclerosis (Effective 2016)*, Ulcerative Colitis (Effective 2016)*, Complex Regional Pain Syndrome, Type 1 and Type II (Effective 2016)*, Cerebral Palsy (Effective 2016), Cystic Fibrosis (Effective 2016), Irreversible Spinal Cord Injury with Objective Neurological Indication of Intractable Spasticity (Effective 2016), Terminal Illness Requiring End-Of-Life Care (Effective 2016), Uncontrolled Intractable Seizure Disorder (Effective 2016), Spasticity or Neuropathic Pain Associated with Fibromyalgia (Effective 2018)*, Severe Rheumatoid Arthritis (Effective 2018)*, Post Herpetic Neuralgia (Effective 2018)*, Hydrocephalus with Intractable Headache (Effective 2018)*, Intractable Headache Syndromes (Effective 2018)*, Neuropathic Facial Pain (Effective 2018)*, Muscular Dystrophy (Effective 2018)*, Osteogenesis Imperfecta (Effective 2018)*, Chronic Neuropathic Pain Associated with Degenerative Spinal Disorders (Effective 2018)*, Interstitial Cystitis (Effective 2019)*, MALS Syndrome (Median Arcuate Ligament Syndrome) (Effective 2019)*, Vulvodynia and Vulvar Burning (Effective 2019)*, Intractable Neuropathic Pain that Is Unresponsive to Standard Medical Treatments (Effective 2019)*, Tourette Syndrome (Effective 2019)*, Chronic Pain of at least 6 months duration associated with a specified underlying chronic condition refractory to other treatment intervention (Effective 2020)*, Ehlers-Danlos Syndrome Associated with Chronic Pain (Effective 2020)* For Patients Under 18, Debilitating Medical Conditions Include: Cerebral Palsy (Effective 2016), Cystic Fibrosis (Effective 2016), Irreversible Spinal Cord Injury with Objective Neurological Indication of Intractable Spasticity (Effective 2016), Severe Epilepsy (Effective 2016), Terminal Illness Requiring End-Of-Life Care (Effective 2016), Uncontrolled Intractable Seizure Disorder (Effective 2016), Muscular Dystrophy (Effective 2018)*, Osteogenesis Imperfecta (Effective 2018)*, Intractable Neuropathic Pain that Is Unresponsive to Standard Medical Treatments (Effective 2019)*, Tourette Syndrome for patients who have failed standard medical treatment (Effective 2019)*, Conditions were approved by the Regulation Review Committee via the recommendation of the Board of Physicians and Commissioner of Consumer Protection.

California: Cura CA: Manufacturing – Vapes / Tinctures / etc.: CDPH-10001355, Curaleaf: Manufacturing – Select Gummies: CDPH-10003298

Florida: Medical Marijuana is not available to individuals under the age of 18 unless by a registered caregiver. The transfer of medical marijuana to another person is illegal. This product has not been analyzed or approved by the FDA. There is limited information on the side effects of using this product, and there may be associated health risks. Marijuana use during pregnancy and breast-feeding may pose potential harms. It is against the law to drive or operate machinery when under the influence of this product. KEEP THIS PRODUCT AWAY FROM CHILDREN. Qualifying Conditions: Cancer, Epilepsy, Glaucoma, Positive status for human immunodeficiency virus, Acquired immune deficiency syndrome, Posttraumatic stress disorder, Amyotrophic lateral sclerosis, Crohn’s disease, Parkinson’s disease, Multiple sclerosis, Medical conditions of the same kind or class as or comparable to those enumerated in paragraphs (a)-(j), A terminal condition diagnosed by a physician other than the qualified physician issuing the physician certification, Chronic nonmalignant pain.

Illinois: Autism, Agitation of Alzheimer’s disease, HIV/AIDS, Amyotrophic lateral sclerosis (ALS), Anorexia nervosa, Arnold-Chiari malformation, Cancer, Cachexia/wasting syndrome, Causalgia, Chronic inflammatory demyelinating polyneuropathy, Chronic pain, Crohn’s disease, CRPS (complex regional pain syndrome Type II), Dystonia, Ehlers-Danlos syndrome, Fibrous Dysplasia, Glaucoma, Hepatitis C Hydrocephalus, Hydromyelia, Interstitial cystitis, Irritable bowel syndrome, Lupus, Migraines, Multiple Sclerosis, Muscular Dystrophy, Myasthenia Gravis, Myoclonus, Nail-patella syndrome, Neuro-Bechet’s autoimmune disease, Neurofibromatosis, Neuropathy, Osteoarthritis, Parkinson’s disease, Polycystic kidney disease (PKD), Post-Concussion Syndrome, Post-Traumatic Stress Disorder (PTSD), Reflex sympathetic dystrophy, Residual limb pain, Rheumatoid arthritis, Seizures (including those characteristic of Epilepsy), Severe fibromyalgia, Sjogren’s syndrome, Spinal cord disease (including but not limited to arachnoiditis) Spinal cord injury is damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity, Spinocerebellar ataxia, Superior canal dehiscence syndrome, Syringomyelia, Tarlov cysts, Tourette syndrome, Traumatic brain injury, Ulcerative colitis

Maine: 18+ with a valid medical marijuana card and government issued photo ID. See your medical provider for a professional opinion whether you are likely to receive therapeutic or palliative benefit from the medical use of marijuana to treat or alleviate your medical diagnosis.

Maryland: (1) you must be at least 18 years old to view the content; and (2) medical cannabis is for use by certified patients only. Consumption of medical cannabis may impair your ability to drive a car or operate machinery. Please use extreme caution. There may be health risks associated with cannabis use, especially during pregnancy or breast-feeding. Accidental consumption of cannabis by children or animals may result in severe adverse reactions. Keep cannabis out of the reach of children and animals. Qualifying Conditions: Anorexia, Cachexia, Chronic pain, Glaucoma, Post-traumatic stress disorder (PTSD), Severe pain, Severe nausea, Seizures, Severe or persistent muscle spasms, Wasting syndrome

Massachusetts: Please Consume Responsibly. There may be health risks associated with consumption of this product. For use only by adults 21 years of age or older. Keep out of the reach of children. This product has not been analyzed or approved by the Food and Drug Administration (FDA). There is limited information on the side effects of using this product, and there may be associated health risks. Marijuana use during pregnancy and breast-feeding may pose potential harms. It is against the law to drive or operate machinery when under the influence of this product. KEEP THIS PRODUCT AWAY FROM CHILDREN. There may be health risks associated with consumption of this product. Marijuana can impair concentration, coordination, and judgment. The impairment effects of Edibles may be delayed by two hours or more. In case of accidental ingestion, contact poison control hotline 1-800-222- 1222 or 9-1-1. This product may be illegal outside of MA. Qualifying Conditions: Amyotrophic lateral sclerosis (ALS), Cancer, Crohn’s disease, Glaucoma, Hepatitis C, HIV/AIDS, Multiple sclerosis, Parkinson’s disease

Michigan: Marijuana product for use only by individuals aged 21 or older. Medical Marijuana for use only by registered qualifying patients or registered primary caregivers. Qualifying Conditions: Cancer, Glaucoma, HIV Positive, AIDS, Hepatitis C, Amyotrophic Lateral Sclerosis, Crohn’s Disease, Agitation of Alzheimer’s Disease, Nail Patella, Post – Traumatic Stress Disorder, Obsessive Compulsive Disorder, Arthritis, Rheumatoid Arthritis, Spinal Cord Injury, Colitis, Inflammatory Bowel Disease, Ulcerative Colitis, Parkinson’s Disease, Tourette’s Disease, Autism, Chronic Pain, Cerebral Palsy, A chronic or debilitating disease or medical condition or its treatment that produces 1 or more of the following:Cachexia or Wasting Syndrome, Severe and Chronic Pain, Severe Nausea, Seizures (Including but not limited to those characteristic of epilepsy), Severe and Persistent Muscle Spasms (Including but not limited to those characteristic of multiple sclerosis)

North Dakota: Qualifying Conditions: Terminal Illness, Acquired Immune Deficiency Syndrome, Agitation of Alzheimer’s Disease or related Dementia, Amyotrophic Lateral Sclerosis, Anorexia Nervosa, Anxiety Disorder, Autism Spectrum Disorder, Brain Injury, Bulimia Nervosa, Cancer, Crohn’s Disease, Decompensated Cirrhosis caused by Hepatitis C, Ehlers-Danlos Syndrome, Endometriosis, Epilepsy, Fibromyalgia, Glaucoma, Interstitial Cystitis, Migraine, Neuropathy, Positive Status for Human Immunodeficiency Virus, Post-traumatic Stress Disorder, Rheumatoid Arthritic, Spinal Stenosis or chronic back pain, including neuropathy or damage to the nervous tissue of spinal cord with objective, neurological indication of intractable spasticity, Tourette Syndrome, A chronic or debilitating disease or medical condition or treatment for such disease or medical condition that produces one or more of the following: Cachexia or wasting syndrome, Severe debilitating pain that has not responded to previously prescribed medication or surgical measures for more than three months or for which other treatment options produced serious side effects, Intractable nausea, Seizures, Severe and persistent muscle spasms, including those characteristic of multiple sclerosis.

New Jersey: i. This product has not been analyzed or approved by the FDA. ii. Do not drive or operate heavy machinery when under the influence of this product. iii. This product is not intended for children, unless authorized by a doctor. iv. This product is for medical use by a qualifying patient and not for resale v. This product is not intended to diagnose, treat, cure or prevent any disease. Qualifying Conditions: Amyotrophic lateral sclerosis, Anxiety, Cancer, Chronic Pain, Dysmenorrhea, Glaucoma, Inflammatory bowel disease, including Crohn’s disease, Intractable skeletal spasticity, Migraine, Multiple sclerosis, Muscular dystrophy, Opioid Use Disorder, Positive status for Human Immunodeficiency Virus (HIV) and Acquired Deficiency Syndrome (AIDS), Post-Traumatic Stress Disorder (PTSD), Seizure disorder, including epilepsy, Terminal illness with prognosis of less than 12 months to live, Tourette Syndrome

New York: Qualifying Conditions: Amyotrophic lateral sclerosis (ALS), Cancer, Chronic pain, Damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity, Epilepsy, HIV /AIDS, Inflammatory bowel disease, Huntington’s disease, Multiple sclerosis, Neuropathy, Opioid use disorder (only if enrolled in a treatment program pursuant to article 32 of the mental hygiene law.), Opioid replacement

Nevada: (1)Keep out of reach of children (2)For use only by adults 21 years of age and older. Qualifying Conditions: Acquired immune deficiency syndrome; An anxiety disorder, An autism spectrum disorder, An autoimmune disease, Anorexia nervosa, Cancer, Dependence upon or addiction to opioids, Glaucoma, Cachexia, Muscle spasms, including, without limitation, spasms caused by multiple sclerosis, Seizures, including, without limitation, seizures caused by epilepsy, Nausea or Severe or chronic pain, A medical condition related to the human immunodeficiency virus, Aneuropathic condition, whether or not such condition causes seizures

Ohio: (1) You must be at least 18 years old to view the content (2) Medical cannabis is for medical use by certified patients only. Consumption of medical cannabis can impair concentration, coordination, and judgment. Smoking medical marijuana is not permitted in the State of Ohio. Do not operate a vehicle or machinery under the influence of marijuana. Keep out of reach of children. Qualifying Conditions: Amyotrophic lateral sclerosis (ALS) Alzheimer’s disease, Cachexia, Wasting syndrome, Cancer, Chronic traumatic encephalopathy, Crohn’s disease, Epilepsy or another seizure disorder, Fibromyalgia, Glaucoma, Hepatitis C, Inflammatory bowel disease, Multiple sclerosis, Pain that is either chronic and severe or intractable, Parkinson’s disease, HIV/AIDS, Post-traumatic stress disorder, Sickle cell anemia, Spinal cord disease or injury, Tourette’s syndrome, Traumatic brain injury, Ulcerative colitis

Oklahoma: An Oklahoma licensed and practicing physician or podiatrist may recommend medical cannabis for any condition they believe will be improved through the administration of medical cannabis

Oregon: Do not operate a vehicle or machinery under the influence of this drug., For use only by adults twenty-one years of age and older. Keep out of the reach of children.

Pennsylvania: Qualifying Conditions: Amyotrophic lateral sclerosis, Anxiety disorders, Autism, Cancer, including remission therapy, Crohn’s disease, Damage to the nervous tissue of the central nervous system (brain-spinal cord) with objective neurological indication of intractable spasticity, and other associated neuropathies, Dyskinetic and spastic movement disorders, Epilepsy, Glaucoma, HIV / AIDS, Huntington’s disease, Inflammatory bowel disease, Intractable seizures, Multiple sclerosis, Neurodegenerative diseases, Neuropathies, Opioid use disorder for which conventional therapeutic interventions are contraindicated or ineffective, or for which adjunctive therapy is indicated in combination with primary therapeutic interventions, Parkinson’s disease, Post-traumatic stress disorder, Severe chronic or intractable pain of neuropathic origin or severe chronic or intractable pain, Sickle cell anemia, Terminal illness, Tourette syndrome.

Utah: Qualifying Conditions: PTSD, Autism, Epilepsy/debilitating seizures, Ulcerative colitis or Crohn’s disease, HIV/AIDS, Cachexia, Cancer, Alzheimer’s disease, Persistent nausea unrelated to pregnancy, Multiple sclerosis/ Debilitating muscle spasms, Amyotrophic lateral sclerosis, Crohn’s disease or ulcerative colitis, Pain Management (longer than 2 weeks), Hospice Care. Cannabis has intoxicating effects and may be addictive. Do not operate a vehicle or machinery under its influence. KEEP OUT OF REACH OF CHILDREN. This product is for Medical use only. Use only as directed by a qualified medical provider. THIS PRODUCT CONTAINS MARIJUANA.

Colorado: Qualifying Conditions: Cancer, Glaucoma. HIV or AIDS. Cachexia. Persistent muscle spasms. Seizures. Severe nausea. Severe pain.Post-Traumatic Stress Disorder (PTSD).An Autism Spectrum Disorder.Any condition for which a physician could prescribe an opioid.Contains Marijuana. Keep away from Children. For use by adults 21 years or older. Lic # 404R-00025

Vermont: May communicate with registered patients and caregivers through electronic means, U.S. mail or voice means, provided that written authorization for such communication has been received. This authorization may be withdrawn by the registered patient or caregiver at any time. Dispensaries shall develop the appropriate procedures and forms necessary for registered patients and caregivers to “opt in” and to “opt out” of such communications; Qualifying Conditions: cancer, multiple sclerosis, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, or the treatment of these conditions, if the disease or the treatment results in severe, persistent, and intractable symptoms; or (B) a disease, medical condition, or its treatment that is chronic, debilitating, and produces severe, persistent, and one or more of the following intractable symptoms: cachexia or wasting syndrome; severe pain; severe nausea; or seizures.

Arizona: Qualifying Conditions: 1. Cancer; 2. Glaucoma; 3. Human immunodeficiency virus; 4. Acquired immune deficiency syndrome; 5. Hepatitis C; 6. Amyotrophic lateral sclerosis; 7. Crohn’s disease; 8. Agitation of Alzheimer’s disease; 9. A chronic or debilitating disease or medical condition or the treatment for a chronic or debilitating disease or medical condition that produces cachexia or wasting syndrome; 10. A chronic or debilitating disease or medical condition or the treatment for a chronic or debilitating disease or medical condition that produces severe and chronic pain; 11. A chronic or debilitating disease or medical condition or the treatment for a chronic or debilitating disease or medical condition that produces severe nausea; 12. A chronic or debilitating disease or medical condition or the treatment for a chronic or debilitating disease or medical condition that produces seizures, including those characteristic of epilepsy; 13. A chronic or debilitating disease or medical condition or the treatment for a chronic or debilitating disease or medical condition that produces severe or persistent muscle spasms, including those characteristic of multiple sclerosis; or 14. A debilitating medical condition approved by the Department under A.R.S. § 36-2801.01 and R9-17-106.

Arkansas: Marijuana is for use by qualified patients only. Keep out of reach of children. Marijuana use during pregnancy or breastfeeding poses potential harms. Marijuana is not approved by the FDA to treat, cure, or prevent any disease. Do not operate a vehicle or machinery under the influence of marijuana. Qualifying Conditions: a. Cancer, glaucoma, positive status for human immunodeficiency virus/acquired immune deficiency syndrome, hepatitis C, amyotrophic lateral sclerosis, Tourette’s syndrome, Crohn’s disease, ulcerative colitis, post-traumatic stress disorder, severe arthritis, fibromyalgia, Alzheimer’s disease, or the treatment of these conditions; b. A chronic or debilitating disease or medical condition or its treatment that produces one (1) or more of the following: cachexia or wasting syndrome; peripheral neuropathy; intractable pain, which is pain that has not responded to ordinary medications, treatment or surgical measures for more than six (6) months; severe nausea; seizures, including without limitation those characteristic of epilepsy; or severe and persistent muscle spasms, including, without limitation those characteristic of multiple sclerosis; and c. Any other medical condition or its treatment approved by the Department pursuant to its Rules and the Amendment.